Abstract
Numerous publications pertaining identification of SARS-CoV virus appeared from 2003. A metaanalysis of the studies has shown an effectiveness of real-time reverse transcriptase polymerase chain reaction in Coronavirus genus detection. First, the authors describe the exposure risk for the medical and laboratory personnel. There are several risk points in the chain of lab activities. The way to current standard of coronavirus is shown as well as the elements of the molecular assays. Serological test are supplementary to the RT-PCR in selected clinical scenarios. The diagnostic algorithm is proposed with the use of the combination of the tests. This is for increasing the chance of detection of SARS-CoV-2 in unsymptomatic patients, as well as mild cases under surveillance, quarantine and isolation. The serological studies may be useful in epidemiological investigations and future retrospective studies on COVID-19 pandemic.
References
World Health Organization. Novel Coronavirus (2019-nCoV). Situation report – htpp://www.who.int/docs/default-source/coronaviruses/situation-reports/20200121-strip-1‑2019-ncov.pdf.
Zhou P, Yang XL, Wang XG, et al. Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. BioRxiv; 2020 Jan 1.
DOI: 10.1101/2020.01.22.914952.
Gorbalenya AE, Baker SC, Baric RS, et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020; (5):536‑544. DOI:10.1038/s41564‑020‑0695-z.
Lin C, Ye R, Xia YL. A meta-analysis to evaluate the effectiveness of real-time PCR for diagnosing novel coronavirus infections. Genet Mol Res 2015;14:15634‑41.DOI:10.4238/2015.December.1.15.
Ustawa z dnia 14 grudnia 2012 r. o odpadach (Dz. U. 2013 poz. 21 z póź. zm.); Rozporządzenie Ministra Zdrowia z dnia 5 października 2017 r. w sprawie szczegółowego sposobu postępowania z odpadami medycznymi (Dz. U. 2017 poz. 1975).
World Health Organization, Laboratory biorisk management for laboratories handling human specimens suspected or confirmed to contain novel coronavirus: Interim recommendations, https://www.who.int/csr/disease/coronavirus_infections/Biosafety, reviewed 5th April 2020.
WHO Biosafety Guidelines for handling of SARS Specimens. World Health Organization. Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases: interim guidance, 2nd March 2020. www.who.int.
Chang L, Yan Y, Wang L. Coronavirus disease 2019: coronaviruses and blood safety. Transfus Med Rev 2020.
DOI:10.1016/j.tmrv.2020.02.003.
Ustawa z dnia 27 lipca 2001 r. o diagnostyce laboratoryjnej. Rozporządzenie Ministra Zdrowia z dnia 3 marca 2004 r. w sprawie wymagań, jakim powinno odpowiadać medyczne laboratorium diagnostyczne (Dz. U. 2019 poz. 849; 2004).
World Health Organization. Guidance on regulations for the transport of infectious substances 2019‑2020: applicable from 1 January 2019. World Health Organization; 2019.
Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill 2020; 25 (3). DOI:10.2807/1560‑7917.
Chu DK, Pan Y, Cheng S, et al. Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia. Clin Chem 2020. DOI:10.1093/clinchem/hvaa029.
Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020. DOI: 10.1056/NEJMoa2001017.
Chan PK, To WK, Ng KC, et al. Laboratory diagnosis of SARS. Emerg Infect Dis 2004;10 (5):825. DOI:10.3201/eid1005.030682.
Emery SL, Erdman DD, Bowen MD, et al. Real-time reverse transcription-polymerase chain reaction assay for SARS-associated coronavirus. Emerg Infect Dis 2004; 10 (2):311.
DOI:10.3201/eid1002.030759.
Ksiazek TG, Erdman D, Goldsmith CS, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003; 15 (20):1953‑66.DOI:10.1056/NEJMoa030781.
Nitsche A, Schweiger B, Ellerbrok H, et al. SARS coronavirus detection. Emerg Infect Dis 2004; 10 (7):1300. DOI:10.3201/eid1007.030678.
Zhai J, Briese T, Dai E, et al. Real-time polymerase chain reaction for detecting SARS coronavirus, Beijing, 2003. Emerg Infect Dis 2004; 10 (2):311. DOI:10.3201/eid1002.030799.
Poon LL, Chan KH, Wong OK, et al. Detection of SARS coronavirus in patients with severe acute respiratory syndrome by conventional and real-time quantitative reverse transcription-PCR assays. Clin Chem 2004; 50 (1):67‑72. DOI:10.1373/clinchem.2003.023663.
Corman V, Müller M, Costabel U, et al. Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Euro Surveill 2012; 17 (49):27.
Lu X, Whitaker B, Sakthivel SK, et al. Real-time reverse transcription-PCR assay panel for Middle East respiratory syndrome coronavirus. J Clin Microbiol 2014; 52 (1):67‑75. DOI:10.1128/JCM.02533‑13.
Huang P, Wang H, Cao Z, et al. A rapid and specific assay for the detection of MERS-CoV. Front Microbiol 2018; 29 (9):1101. DOI: 10.3389/fmicb.2018.01101.
Hashemzadeh MS, Rasouli R, Zahraei B, et al. Development of dual taqman based one-step rRT-PCR assay panel for rapid and accurate diagnostic test of MERS-CoV: a novel human coronavirus, ahead of hajj pilgrimage. Iran Red Crescent Med J 2016; 18 (11). DOI:10.5812/ircmj.23874.
Center of Disease Control and Prevention. CDC. https://www.cdc.gov/coronavirus/2019-ncov/lab/rt-pcr-panel-primer-probes.html. USA 2020.
Center of Disease Control and Prevention. CDC. https://www.cdc.gov/coronavirus/2019-ncov/lab/rt-pcr-detection-instructions.html. CDC 2020.
Specific primers and probes for detection 2019 novel coronavirus. National Institute for Viral Disease Control and Prevention. China 2020. http://ivdc.chinacdc.cn/kyjz/202001/t20200121_211337.html).
Diagnostic detection of 2019-nCoV by real-time RT-PCR, protocol 2020. https://www.who.int/docs/default-source/coronaviruse/protocol-v2‑1.pdf?sfvrsn=a9ef618c_2.
Detection of 2019 novel coronavirus (2019-nCoV) in suspected human cases by RT-PCR, protocol, HKU MED, LKS Faculty of Medicine. School of Public Health. 2020. https://www.who.int/docs/default-source/coronaviruse/peiris-protocol-16‑1-20.pdf?sfvrsn=af1aac73_4.
PCR and sequencing protocol for 2019-nCoV – Department of Medical Sciences, Ministry of Public Health. Thailand 2020. https://www.who.int/docs/default-source/coronaviruse/conventional-rt-pcr-followed-by-sequencing-for-detection-of-ncov-rirl-nat-inst-health-t.pdf?sfvrsn=42271c6d_4.
PCR and sequencing protocols for 2019-nCoV – National Institute of Infectious Diseases, Protocol. Japan 2020.
https://www.who.int/docs/default-source/coronaviruse/method-niid-20200123‑2.pdf?sfvrsn=fbf75320_7.
US CDC Real-Time RT-PCR Panel for Detection 2019-Novel Coronavirus, Center of Disease Control and Prevention; Protocol. USA 2020. https://www.who.int/docs/default-source/coronaviruse/uscdcrt-pcr-panel-for-detection-instructions.pdf?sfvrsn=3aa07934_2.
US CDC Real-Time RT-PCR Panel for Detection 2019-Novel Coronavirus, 2019-Novel Coronavirus (2019-nCoV) Real-time rRT-PCR Panel Primers and Probes. Center of Disease Control and Prevention, Protocol. USA 2020. https://www.who.int/docs/default-source/coronaviruse/uscdcrt-pcr-panel-primer-probes.pdf?sfvrsn=fa29cb4b_2.
Real-time RT-PCR assays for the detection of SARS-CoV-2, Institute of Pasteur, Paris, Protocol. France 2020. https://www.who.int/docs/default-source/ coronaviruse/ real-time-rt- pcr-assays-for -the-detection-of-sars-cov-2-institut-pasteur-paris.pdf?sfvrsn=3662fcb6_2.
Algorytm postępowania diagnostycznego w przypadku osób zakażonych/podejrzanych o zakażenie 2019-nCoV od dnia 05.03.2020. Państwowy Zakład Higieny – Narodowy Instytut Zdrowia Publicznego. Polska 2020.
Yam WC, Chan KH, Poon LL, et al. Evaluation of reverse transcription-PCR assays for rapid diagnosis of severe acute respiratory syndrome associated with a novel coronavirus. J Clin Microbiol 2003; 41 (10):4521‑4524. DOI:10.1128/JCM.41.10.4521‑4524.2003.
Cai X, Chen J, Hu J, et al. A Peptide-based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Corona Virus Disease 2019 (COVID-19). medRxiv. 1 Jan 2020. DOI:10.1101/2020.02.22.20026617.
Woo PC, Lau SK, Wong BH, et al. Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia. J Clin Microbiol. 2005; 43 (7):3054‑3058. DOI:10.1128/JCM.43.7.3054‑3058.2005.
Liu L, Liu W, Wang S, et al. A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 238 admitted hospital patients. medRxiv 2020. DOI:10.1101/2020.03.06.20031856.
Zhao J, Yuan Q, Wang H, et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. The Lancet, preprint, manuscript number THELANCET -D- 20‑02366.
Jia X, Zhang P, Tian Y, et al. Clinical significance of IgM and IgG test for diagnosis of highly suspected COVID-19 infection. medRxiv 2020. DOI:10.1101/2020.02.28.20029025.
Zhang J, Liu J, Li N, et al. Serological detection of 2019-nCoV respond to the epidemic: A useful complement to nucleic acid testing. medRxiv 2020. DOI:10.1101/2020.03.04.20030916.
Xiang J, Yan M, Li H, et al. Evaluation of Enzyme-Linked Immunoassay and Colloidal Gold-Immunochromatographic Assay Kit for Detection of Novel Coronavirus (SARS-Cov-2) Causing an Outbreak of Pneumonia (COVID-19). medRxiv 2020. DOI: 10.1101/2020.02.27.20028787.
This work is licensed under a Creative Commons Attribution 4.0 International License.